Education
About Us
Working with TipRanks
Follow Us
Inspire Medical (INSP)
:INSP
INSP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$70.77 - $216.01
Previous CloseN/A
Volume95.34K
Average Volume (3M)1.02M
Market Cap
$2.19B
Enterprise Value$3.56B
Total Cash (Recent Filing)$300.89M
Total Debt (Recent Filing)$33.06M
Price to Earnings (P/E)44.4
Beta0.39
Next Earnings
Nov 04, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding29,574,316
10 Day Avg. Volume1,054,919
30 Day Avg. Volume1,018,377
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.63
Enterprise Value/Revenue4.13
Enterprise Value/Gross Profit4.89
Enterprise Value/Ebitda43.85
Forecast
1Y Price Target
$141.58Price Target Upside84.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Bulls Say, Bears Say
Bulls Say
Market OpportunityAn attractive opportunity to buy a clinically differentiated company serving unmet need in a less than 5% penetrated market with an impressive growth outlook.
ValuationThe stock is trading at significantly lower multiples compared to its peers, suggesting it may be undervalued.
Bears Say
CompetitionThere is a belief that the GLP-1 bear thesis can't be disproved, and there may be underappreciated downside from continued adoption of GLP-1s in this patient population.
Leadership ChangeINSP announced that CFO Rick Buchholz will be stepping down to pursue other opportunities.
Product RolloutThe slower-than-expected Inspire V rollout and soft guidance are key areas of investor scrutiny due to potential volume headwinds from GLP-1 adoption.
Inspire Medical Systems News
INSP FAQ
What was Inspire Medical’s price range in the past 12 months?
Inspire Medical lowest stock price was $70.77 and its highest was $216.01 in the past 12 months.
What is Inspire Medical’s market cap?
Inspire Medical’s market cap is $2.19B.
When is Inspire Medical’s upcoming earnings report date?
Inspire Medical’s upcoming earnings report date is Nov 04, 2025 which is in 30 days.
How were Inspire Medical’s earnings last quarter?
Inspire Medical released its earnings results on Aug 04, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.202 by $0.248.
Is Inspire Medical overvalued?
According to Wall Street analysts Inspire Medical’s price is currently Undervalued.
Does Inspire Medical pay dividends?
Inspire Medical does not currently pay dividends.
What is Inspire Medical’s EPS estimate?
Inspire Medical’s EPS estimate is -0.2.
How many shares outstanding does Inspire Medical have?
Inspire Medical has 29,574,316 shares outstanding.
What happened to Inspire Medical’s price movement after its last earnings report?
Inspire Medical reported an EPS of $0.45 in its last earnings report, beating expectations of $0.202. Following the earnings report the stock price went down -32.351%.
Which hedge fund is a major shareholder of Inspire Medical?
Currently, no hedge funds are holding shares in INSP
Inspire Medical Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$141.58 (84.88% Upside)
$141.58 (84.88% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 68.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.8%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.64%
12-Months-Change
Fundamentals
Return on Equity
8.07%
Trailing 12-Months
Asset Growth
10.13%
Trailing 12-Months
Company Description
Inspire Medical
Inspire Medical Systems, Inc. is a medical technology company focused on developing innovative solutions for patients suffering from obstructive sleep apnea (OSA). The company is primarily engaged in the design and commercialization of its flagship product, the Inspire therapy system, which is a surgically implanted device that stimulates the hypoglossal nerve to maintain an open airway during sleep. Inspire operates within the healthcare sector, targeting both patients and healthcare providers, aiming to enhance treatment options for sleep apnea beyond traditional CPAP devices.
INSP Company Deck
INSP Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed sentiment with several positive highlights, including revenue growth and clinical study success; however, these were offset by significant lowlights, such as reduced guidance, EPS decrease, rollout challenges for Inspire V, and increased operating expenses.View all INSP earnings summariesINSP Revenue Breakdown
97.02% U.S.
2.98% Other
INSP Stock 12 Month Forecast
Average Price Target
$141.58
▲(84.88% Upside)
Technical Analysis
Integer Holdings
―
LivaNova
―
Irhythm Technologies
―
TransMedics Group
―
PROCEPT BioRobotics
―
Ownership Overview
0.98% Insiders
44.22% Mutual Funds
1.85% Other Institutional Investors
30.17% Public Companies and Individual Investors